Levi Garraway
Tracked across 6 events · 65 articles · First seen Apr 21, 2026 · Last active Sep 24, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Levi Garraway, Roche's chief medical officer, expressed confidence in bexobrutideg's potential to significantly advance treatment for complex blood cancers and other diseases, highlighting Roche's strategic vision for the drug.
Jun 07, 2026 · 22 articles
Tech
F. Hoffmann-La Roche — Genentech, a member of the Roche Group, and its partner Ionis Pharmaceuticals announced positive prespecified interim results from the ongoing Phase III IMAgINATION study evaluating investigational sefaxersen in adults with primary…
Impact: As F. Hoffmann-La Roche — Genentech chief medical officer, Garraway publicly endorsed the interim data, lending clinical credibility to the sefaxersen results.
Sep 23, 2026 · 6 articles
Tech
Impact: Levi Garraway>>>, chief medical officer at F. Hoffmann-La Roche — Genentech>>>, provided commentary on the significance of giredestrant as a major advance in endocrine therapy for early-stage ER-positive breast cancer.
Jun 02, 2026 · 6 articles
Tech
Impact: Levi Garraway, as the chief medical officer and head of Global Product Development at F. Hoffmann-La Roche — Genentech, commented on the strength of the obesity portfolio and the potential for individualized treatment options.
May 27, 2026 · 19 articles
Regulatory
Impact: Levi Garraway>>>, Roche>>>'s Chief Medical Officer, commented on the significance of the filing acceptance for Atezolizumab>>>.
Jun 11, 2026 · 6 articles
Regulatory
Roche announced on 10 September 2026 that the United States — Food and Drug Administration has granted Priority Review to a supplemental Biologics License Application for Enspryng (satralizumab) for the treatment of myelin oligodendrocyte glycoprotein…
Impact: Roche's Chief Medical Officer publicly highlighted the unmet need in MOGAD and Enspryng's potential, serving as the company's scientific spokesperson for the filing.
Sep 09, 2026 · 6 articles
20
Levi Garraway stated resultsSefaxersen Phase III IgAN...
ERGEN INTELLIGENCE
Track Levi Garraway live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard